地理萎缩候选表型及其不同生长参数的描述
这项前瞻性队列研究纳入48例患者共81只眼,基于眼底自发荧光(FAF)纵向图像将地理萎缩(GA)分为三种候选表型,并用人工智能分割模型计算病变面积与生长速率。结果显示,视盘周围受累及大融合多灶型、小而多灶型表型与更严重的生长轨迹相关。
要点
- 视盘周围受累与更高的模型最大GA生长速率和最大GA尺寸独立相关。
- 校正视盘周围受累后,大融合多灶型和小而多灶型预测最大GA尺寸大于单灶中心凹型。
- 小而多灶型相比单灶中心凹型具有更快的平方根生长速率和模型最大GA生长速率。
核心结论
- 描述了三种候选GA表型及其不同生长参数,大融合多灶型和小而多灶型表型具有更严重的生长轨迹。
- 视盘周围受累预示更严重的结局。
研究设计与样本
- 前瞻性队列研究,纳入2014年9月至2022年9月在科罗拉多大学年龄相关性黄斑变性登记处入组、随访至2023年4月且至少有5个FAF时间点的GA患者。
- 共纳入48例患者的81只眼,平均年龄80岁(SD:8),平均基线GA面积为6.4mm²(SD:7.5)。
- 由两名分级者审阅纵向FAF图像判定候选GA表型:单灶中心凹型(UF)、大融合多灶型(LCM)、小而多灶型(SNM),并记录是否伴视盘周围成分。
- 使用基于人工智能的分割模型自动勾画GA病变并计算面积,经人工审阅调整;计算每只眼的平方根转换生长速率,并进行Gompertz模型估计最大GA生长速率和预测GA尺寸。
- 采用广义估计方程的线性回归估计表型与GA生长速率指标之间的关联。
主要发现
- 单变量分析中,伴视盘周围成分的眼具有更高的模型最大GA生长速率(beta 0.37;95%CI:0.16,0.59;P<0.001)和最大GA尺寸(beta 0.24;95%CI:0.10,0.38;P<0.001)。
- 校正视盘周围成分后,LCM表型的预测最大GA尺寸大于UF表型(beta 0.10;95%CI:0.03,0.18;P=0.009),SNM表型与UF表型的差异为beta 0.10(95%CI:-0.00,0.21;P=0.059)。
- SNM表型相比UF表型具有更快的平方根生长速率(beta 0.09;95%CI:0.03,0.16;P=0.005)和模型最大GA生长速率(beta 0.29;95%CI:0.13,0.44;P<0.001)。
- LCM表型相比UF表型的平方根生长速率差异为 borderline(P=0.05)。
- SNM表型的模型最大GA生长速率较LCM表型 marginally 更高(估计边际均值差0.200mm/y;95%CI:-0.00,0.40;P=0.054)。
关键数值与推荐
- 候选GA表型定义:单灶中心凹型(UF)、大融合多灶型(LCM)、小而多灶型(SNM),并记录是否伴视盘周围成分。
- 纳入标准:至少5个FAF时间点,随访期内纵向FAF图像可用于表型判定。
- 生长参数包括平方根转换生长速率、Gompertz模型估计的最大GA生长速率和预测最大GA尺寸。
临床怎么用
- 基于FAF的GA表型分类和视盘周围成分评估可能有助于临床预后判断。
- 不同GA表型的生长轨迹差异可能对临床试验解读产生影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Describe distinct candidate geographic atrophy (GA) phenotypes in age-related macular degeneration and their different growth parameters. DESIGN: Prospective cohort study. METHOD: Patients with GA enrolled in the University of Colorado age-related macular degeneration Registry from 9/2014 to 9/2022, with follow-up through 4/2023, with ≥five fundus autofluorescence (FAF) time points were included. Longitudinal FAFs for each patient's eye were reviewed by two graders for candidate GA phenotype: (1) unifocal foveal-involving (UF), (2) large coalescing multifocal (LCM), (3) small numerous multifocal (SNM), and presence of a concomitant peripapillary component. Each FAF image was processed using an artificial intelligence (AI) based segmentation model to automatically delineate GA lesions and calculate lesion area, with manual review/adjustment. Square root transformed (SQRT) growth rate was calculated per eye. Gompertz modelling of GA growth was performed to estimate maximum GA growth rate and projected GA size. Linear regression using generalized estimating equations estimated associations between phenotypes and measures of GA growth rate. RESULTS: 81 eyes with GA from 48 patients were included. Average subject age was 80 years (SD:8). Average baseline GA size was 6.4mm2 (SD:7.5). Eyes with a peripapillary component had higher modeled maximum GA growth rates (beta 0.37; 95% confidence interval [CI]:0.16,0.59; P<0.001) and maximum GA size (beta 0.24; 95%CI:0.10,0.38; P<0.001) in univariate analysis. After adjusting for a peripapillary component, the LCM and SNM phenotypes had larger predicted maximum GA sizes than the UF phenotype (beta 0.10; 95%CI:0.03,0.18; P=0.009 and beta 0.10; 95%CI:-0.00,0.21; P=0.059, respectively). The SNM phenotype had faster SQRT and modeled maximum GA growth rates compared to the UF phenotype (beta 0.09; 95%CI:0.03,0.16; P=0.005 and beta 0.29; 95%CI:0.13,0.44; P<0.001, respectively), and the LCM phenotype had borderline faster SQRT growth rates than the UF phenotype (P=0.05). Further, the SNM phenotype had marginally higher modeled maximum GA growth rates than the LCM phenotype (estimated marginal mean difference 0.200mm/y; 95%CI:-0.00,0.40; P=0.054). CONCLUSIONS: We describe three candidate GA phenotypes and their different growth parameters. The large coalescing multifocal and small numerous multifocal phenotypes had more severe growth trajectories, and presence of a peripapillary component portended more severe outcomes. This may have implications for clinical trial interpretation and clinical prognostication.
引用
- de Carlo Forest TE, Mathias MT, Grove N, et al. Describing Candidate Geographic Atrophy Phenotypes and Their Different Growth Parameters. Am J Ophthalmol. 2026. PMID: 42624312. doi:10.1016/j.ajo.2026.08.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。